Dexpramipexole As a Steroid-Sparing Agent in Hypereosinophilic Syndromes (HES): An Open-Label Proof-of-Concept Study

被引:2
作者
Panch, Sandhya R. [1 ]
Bozik, Michael [2 ]
Brown, Thomas [3 ]
Demarco, Ulrike [2 ]
Hahn, Jamie [4 ]
Komarov, Alexander [2 ]
Magee, Tamika [3 ]
Makiya, Michelle [5 ]
Prussin, Calman [2 ]
Signore, Armando [2 ]
Sullivan, Mary [2 ]
Wetzler, Lauren [3 ]
Dunbar, Cynthia E. [6 ]
Dworetzky, Steven [2 ]
Maric, Irina [4 ]
Klion, Amy D. [5 ]
机构
[1] Natl Inst Hlth, Dept Transfus Med, Ctr Clin, Bethesda, MD USA
[2] Knopp Biosciences, Pittsburgh, PA USA
[3] Leidos Biomedical Res Inc, Frederick, MD USA
[4] NIH Clin Ctr, Dept Lab Med, Bethesda, MD USA
[5] Natl Inst Hlth, Parasit Dis Lab, NIAID, Bethesda, MD USA
[6] Natl Inst Hlth, Natl Heart Lung & Blood Inst, Hematol Branch, Bethesda, MD USA
关键词
D O I
10.1182/blood.V128.22.1327.1327
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1327
引用
收藏
页数:4
相关论文
empty
未找到相关数据